User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01, R21 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells and the tumor microenvironment.
This FOA will utilize the Research Project Grant (R01) mechanism and runs in parallel with a companion FOA of identical scope, PAR-22-140 , which utilizes the Research Exploratory/Developmental Research Grant (R21) mechanism.
Deadlines:
- R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
- R21 Due Dates: Feb. 16, Jun. 16, Oct. 16
PAR-22-139 Expiration Date May 08, 2025
Specialties
Eligibility Requirements
Sponsor Details
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Grant
Final Deadline:
Oct 05, 2024
Funding Amount:
$2,500,000
This program has not been verified by Trialect.
Host Details
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts